Home » PAR, MN AGREE TO GENERIC DRUG PACT
PAR, MN AGREE TO GENERIC DRUG PACT
Par Pharmaceutical Cos. said Monday that it agreed to act on behalf of Turkish
drug maker MN Pharmaceuticals to file up to 10 Food and Drug Administration marketing
applications for generic drugs. Financial terms of the agreement were not disclosed.
Under the agreement, Par will help MN develop up to 10 generic versions of injectable
drugs. MN will be responsible for making the drugs.
Forbes
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May